DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $872,682 | +7.7% | 3,517 | +4.1% | 0.21% | +4.5% |
Q2 2023 | $810,640 | +9.3% | 3,378 | +14.8% | 0.20% | +0.5% |
Q1 2023 | $741,456 | +8.8% | 2,942 | +14.6% | 0.20% | -3.8% |
Q4 2022 | $681,642 | +6.7% | 2,568 | +3.8% | 0.21% | -9.6% |
Q3 2022 | $639,000 | +9.8% | 2,475 | +7.8% | 0.23% | +9.0% |
Q2 2022 | $582,000 | -12.3% | 2,295 | +1.4% | 0.21% | -16.3% |
Q1 2022 | $664,000 | -6.9% | 2,263 | +4.3% | 0.25% | -6.3% |
Q4 2021 | $713,000 | +5.3% | 2,169 | -2.5% | 0.27% | +92.1% |
Q3 2021 | $677,000 | +19.6% | 2,225 | +5.6% | 0.14% | +21.7% |
Q2 2021 | $566,000 | +25.5% | 2,108 | +5.2% | 0.12% | +12.7% |
Q1 2021 | $451,000 | -1.5% | 2,003 | -2.9% | 0.10% | +9.7% |
Q4 2020 | $458,000 | +6.0% | 2,062 | +2.7% | 0.09% | -25.6% |
Q3 2020 | $432,000 | +28.6% | 2,008 | +5.6% | 0.12% | +14.7% |
Q2 2020 | $336,000 | +44.2% | 1,902 | +13.0% | 0.11% | +12.4% |
Q1 2020 | $233,000 | -7.9% | 1,683 | +1.9% | 0.10% | -4.0% |
Q4 2019 | $253,000 | – | 1,651 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |